Unlock instant, AI-driven research and patent intelligence for your innovation.
Amide-containing benzimidazole compounds and applications thereof
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of benzimidazole and compound, applied in the field of T-LAK cell-derived protein kinase inhibitor
Active Publication Date: 2021-12-21
SHENYANG PHARMA UNIVERSITY
View PDF3 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
Therefore, TOPK has become a new target for tumor treatment, and there is no drug specifically targeting this target on the market. Therefore, inhibitors that can specifically bind to TOPK have become a research hotspot for new anti-tumor drugs.
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
preparation example Construction
[0059] The schemes outline the preparative steps used to prepare the compounds of the invention.
[0060]
[0061] process
[0062] Among them, R 1 , R 2 , R 3 , R 5 as mentioned earlier.
[0063] The present invention is described in detail with the following examples. However, it should be understood that the present invention is not limited to the specific recited examples below.
Embodiment 1
[0064] Example 1: 2-{3-{{2-{[(1H-benzimidazol-2-yl)thio]methyl}-3-methylpyridin-4-yl}oxy}propoxy} -Preparation of N-cyclohexylacetamide (compound X01)
[0065] Step A: Preparation of 2-{[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methylthio}-1H-benzimidazole
[0066] 2-Chloromethyl-4-(3-methoxypropoxy)-3-picolinehydrochloride (0.50g, 1.88mmol) was placed in a 125ml eggplant-shaped bottle, and 11ml of ethanol was added to dissolve it, Then 1H-benzimidazole-2-thiol (0.28g, 1.88mmol) and 4ml NaOH (80g / L) were added, refluxed at 68°C for 4h, and the reaction was complete as monitored by TLC. The reaction liquid was poured into a 100ml beaker, cooled naturally to room temperature, a white solid was precipitated, and recrystallized from ethyl acetate and petroleumether (2:1) to obtain 0.58 g of white needle-like crystals, with a yield of 89.3%. m.p.: 115-118°C (literature value: 116-118°C).
[0067] Step B: Preparation of 3-{{2-{[(1H-benzimidazol-2-yl)thio]methyl}-3-methylpyridi...
Embodiment 2
[0071] Example 2: 2-{3-{{2-{[(1H-benzimidazol-2-yl)thio]methyl}-3-methylpyridin-4-yl}oxy}propoxy} -Preparation of N-isopropylacetamide (compound X02)
[0072] Referring to the preparation method of Example 1, 0.57 g of white solid was obtained with a yield of 87.2%. m.p.: 162.9-164.7℃; IR: (KBr,cm -1 )3278,3086,2924,1656,1584,1464,1442,1369,732; 1 H-NMR (400MHz, DMSO): δ8.36(d, 1H, J=7.4Hz, Pyridine-6-H), 8.22(d, 1H, J=5.6Hz, Ar-H), 7.63~7.45(m ,1H,Ar-H),7.44~7.37(m,1H,Ar-H),7.21~7.13(m,2H,Pyridine-5-H,N-H),6.96(d,1H,J=5.7Hz,Ar -H),4.78(s,2H,SCH 2 ),4.69(s,2H,OCH 2 ), 4.12(t, J=6.2Hz, 2H, CH 2 ),3.82(dq,J=13.5,6.7Hz,1H,NCH),3.57(dd,J=10.5,5.7Hz,2H,CH 2 ),2.20(s,3H),1.89(p,J=6.1Hz,2H),1.08(s,3H),1.08(s,3H),1.07(s,3H); ESI-MS(m / z) :429.3([M+H] + ).
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The invention belongs to the technical field of medicine, and relates to 2-[(pyridin-2-ylmethyl)thio]-1H-benzimidazole compounds and their preparation methods and applications. The general formula of described 2-[(pyridin-2-ylmethyl)thio]-1H-benzimidazoles and pharmaceutically acceptable salts is as follows: R 1 , R 2 Same or different, selected from hydrogen, C1‑C8 alkyl, C3‑C6 cycloalkyl, phenyl, halogen substituted phenyl, C1‑C4 alkyl substituted phenyl, C1‑C4 alkoxy substituted phenyl , phenyl substituted with halogen and C1‑C4 alkoxy, phenyl substituted with halogen and C1‑C4 alkoxy, phenyl substituted with halogen substituted C1‑C4 alkyl, benzyl, 4‑benzyloxy Phenyl; or R 1 , R 2 Together with the nitrogen atoms connected to them, they form substituted or unsubstituted morpholinyl, phenylpiperazine or benzhydrylpiperazine; the substituents are C1-C4 alkoxy, C1-C4 alkyl, halogen; R 3 , R 5 Can be selected from H, C1-C4 alkyl. The synthesis method of the compound of the invention is simple and convenient, suitable for industrial production, and has obvious antitumor activity.
Description
technical field [0001] The invention belongs to the technical field of medicine, and relates to 1-aryl-3-{4-[(pyridin-2-ylmethyl)thio]phenyl}urea compounds and a preparation method thereof, and also relates to its function as BRaf kinase, vascular Endothelial growth factor receptor-2 (VEGFR-2), platelet-derived growth factorreceptor-β (Platelet-derived growth factor receptors-β, PDGFR-β) and T-LAK cell-derived proteinkinase (T-LAK cell-originated proteinkinase, TOPK) inhibitor application. Background technique [0002] In recent years, with the continuous elucidation of tumor pathogenesis and the continuous discovery of anti-tumor targets, multi-target inhibition of tumor signal transduction has become an important direction for the development of tumor drugs. Compared with single-target drugs and multiple single-target drugs in combination, multi-target drugs have more advantages: drug interactions can be avoided, adverse reactions can be reduced, and the therapeutic ef...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to View More 
Login to View More 
